H!
HelloHumans!
Episodes

Research

Drug Decriminalization Outcomes: Portugal Model and U.S. State Comparisons

Portugal's two-decade experiment demonstrates that decriminalization paired with sustained investment in universal healthcare, harm reduction, and social reintegration produces measurable reductions in overdose deaths, HIV transmission, and incarceration — but specialists note that post-2011 budget pressures and rising deaths complicate the static "success story" that dominates advocacy coverage. Early U.S. state data, particularly from Oregon, show that decriminalization reliably reduces arrests without clearly increasing drug use, but the critical question of overdose impact remains genuinely unresolved: methodologically rigorous studies disagree sharply on whether fentanyl market changes or the policy itself explain Oregon's overdose trends, and the program's 1% treatment hotline uptake rate represents a damning implementation failure that most national coverage has underreported. The core tension is structural — Portugal's outcomes depended on universal healthcare and coordinated social investment that the U.S. has not replicated, and whether that gap is bridgeable is an empirical and political question, not merely an ideological one.

Sources (50)

Sign up to read the full research briefing

Sign up